Financhill
Back

Guardant Health Quote, Financials, Valuation and Earnings

Guardant Health Price Quote

$35.00
-0.01 (-10.42%)
(Updated: September 2, 2023 at 6:12 AM ET)

Guardant Health Key Stats

Sell
22
Guardant Health (GH) is a Sell

Day range:
$33.17 - $40.48
52-week range:
$20.67 - $62.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.14
P/B ratio:
14.08%

Volume:
6.1M
Avg. volume:
1.4M
1-year change:
-28.65%
Market cap:
$4.1B
Revenue:
$449.5M
EPS:
$-4.91

How Much Does Guardant Health Make?

Is Guardant Health Growing As A Company?

  • What Is Guardant Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.26%
  • What Is Guardant Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Guardant Health Stock Price Performance

  • Did Guardant Health Stock Go Up Last Month?
    Guardant Health share price went down by -7.86% last month
  • Did GH's Share Price Rise Over The Last Year?
    GH share price fell by -28.65% over the past 1 year

What Is Guardant Health 52-Week High & Low?

Guardant Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Guardant Health?

  • How Much Debt Does Guardant Health Have?
    Total long term debt quarterly is $1.1B
  • How Much Cash Does Guardant Health Have?
    Cash and short term investments quarterly total is $1.2B
  • What Is Guardant Health’s Book Value Per Share?
    Book value per share is 2.49

Is Guardant Health Cash Flow Positive?

  • What Is GH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$337.4M
  • What Is Guardant Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $366M
  • What Is Guardant Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $28M

Guardant Health Return On Invested Capital

  • Is Management Doing A Good Job?
    GH return on invested capital is -39.21%
  • What Is Guardant Health Return On Assets?
    ROA measures how assets are converting to revenues and is -29.84%
  • What Is GH Return On Equity?
    ROE is a measure of profitability and is -319.97%

Guardant Health Earnings Date & Stock Price

Guardant Health Competitors

  • Who Are Guardant Health's Competitors?
    Below is a list of companies who compete with Guardant Health or are related in some way:
    • CytoSorbents Corp (CTSO)
    • Delcath Systems Inc (DCTH)
    • Illumina Inc (ILMN)
    • Progyny Inc (PGNY)
    • Star Equity Holdings Inc (STRR)

Guardant Health Dividend Yield

Data Unavailable

Guardant Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.46%
Revenue: 25.66% 5.98%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 53.94
Upside from Last Price: 54.07%

Major Shareholders

  • How many GH shares are owned by institutional investors?
    169.4M GH shares are owned by institutional investors
  • How many GH shares are owned by insiders?
    4.3M GH shares are owned by insiders